75%Confidence
0Views
FDASource
2026-04-10Date
Summary
Annora Pharma's Class III recall for Pitavastatin tablets due to incorrect tablet mixing shows quality control lapses in generic manufacturing, though the low severity limits immediate health risks. This could strain relationships with Northstar Rx LLC and prompt increased oversight of Indian pharmaceutical imports by the FDA.
Actionable: Continue using Pitavastatin from other manufacturers but monitor Annora for recurring quality issues.
AI Confidence: 75%
Data Points
firmAnnora Pharma Private Limited
classificationClass III
statusOngoing
distributionTN
productPitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Phar
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now